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Dengue reemerged in Mauritius in 2009 after an ab-
sence of >30 years, and >200 cases were conﬁ  rmed sero-
logically. Molecular studies showed that the outbreak was 
caused by dengue virus type 2. Phylogenetic analysis of the 
envelope gene identiﬁ  ed 2 clades of the virus. No case of 
hemorrhagic fever was recorded.
M
auritius is a tropical island nation of 1,865 km2 in the 
southwestern Indian Ocean, ≈2,000 km off the coast 
of eastern Africa. It has a population of 1.25 million, with 
≈68% of Indian origin and 27% of predominantly African 
or mixed ancestry. It is classiﬁ  ed by the World Bank as an 
upper-middle-income country. The economy is diversiﬁ  ed; 
textiles, tourism, sugar cane, banking, and business process 
outsourcing are the main sectors. Most Mauritians have a 
sedentary lifestyle.
In 2008, a total of 930,000 visitors traveled to Mauri-
tius for tourism and business; 98% arrived by air (1). They 
were mostly from western Europe (60.5%), Réunion island 
(10.3%), South Africa (9.1%), and India (4.7%).
Mauritius was, for many years, essentially free from 
indigenous dengue and chikungunya disease until 2005 and 
2006 when outbreaks of chikungunya occurred, with Ae-
des albopictus mosquitoes as the vector (2). In the region, 
a well-documented epidemic of dengue fever caused by 
dengue virus type 2 (DENV-2) occurred on Réunion island 
in 1977–1978, and 2 outbreaks were caused by the same 
dengue serotype in the Seychelles in 1976–1977 and 1978–
1979 (3,4). Although no record was made of laboratory-
conﬁ  rmed cases in the 1970s in Mauritius, a subsequent 
seroepidemiologic study suggests that cases of dengue also 
occurred in the country around that time, and it is reason-
able to postulate that they were also caused by DENV-2 
(5). Since then, apart from the occasional imported case, 
no evidence of dengue transmission has been reported for 
>30 years in Mauritius. However, dengue fever reemerged 
in the country in 2009, and we report on the laboratory in-
vestigation of the outbreak.
The Outbreak
At the end of April 2009, a physician from a private 
clinic in Port-Louis, the capital city, reported having seen 
several patients with fever, malaise, diarrhea, increased lev-
els of liver enzymes, and marked thrombocytopenia. Rash 
and arthralgia were not mentioned, and no test was request-
ed for dengue or chikungunya viruses. On June 1, another 
physician requested dengue serologic testing for a patient 
who had fever for the past 10 days, rigors, generalized 
aches and pains, and a petechial rash. The patient had lived 
in Malaysia several years previously but had no history of 
recent travel. His liver enzyme levels were increased, and 
his thrombocyte count was 15,000 cells/μL. At the Central 
Health Laboratory (CHL) in Mauritius, the patient’s serum 
was positive for immunoglobulin (Ig) G and IgM against 
dengue with the Hexagon Dengue rapid immunochromatog-
raphy test (Human GmbH, Wiesbaden, Germany) and nega-
tive for Platelia dengue nonstructural protein 1 (NS1) (Bio-
Rad Laboratories, Marnes-la-Coquette, France).
The next day, 6 patients who had previously been ad-
mitted with fever at the above-mentioned private clinic were 
traced by the Department of Public Health. They all lived in 
the same suburb of the capital city. Serum samples from all 
6 patients showed IgG and IgM against dengue. The Min-
istry of Health and Quality of Life immediately initiated 
an action plan which included mosquito control measures 
by fogging and larviciding, environmental cleaning, and a 
public awareness campaign on how to eliminate mosquito 
breeding sites. The ﬁ  rst 10 positive serum specimens, all of 
which had dengue antibodies were sent for conﬁ  rmation to 
the National Health Laboratory Services in South Africa, 
where all were subsequently found to be positive for den-
gue IgG and IgM by hemagglutination-inhibition test and 
ELISA, respectively.
On June 5, dengue NS1 antigen was detected at CHL 
from serum specimens from 3 patients. Four days later, se-
rum samples from 11 patients that were positive for den-
gue antigen were sent to Tan Tock Seng Hospital in Sin-
gapore for reverse transcription–PCR (RT-PCR) testing. 
Approximately 24 hours later, the laboratory reported that 
DENV RNA was detected in 7 of the samples by real-time 
RT-PCR, with previously described primers using SYBR 
Green and gel electrophoresis (6). The serum samples were 
later found to be positive for DENV-2 by multiplex RT-
PCR with serotype-speciﬁ   c primers, and detection with 
serotype-speciﬁ  c probes by using a Luminex xMAP-based 
assay (Luminex, Austin, TX, USA) (unpub. technique).
Subsequently, nucleotide sequencing and phylogenetic 
analysis of the envelope gene from the PCR products of the 
7 positive serum specimens showed that, although all the 
viruses belonged to the Cosmopolitan genotype, 2 separate 
clades were present. Four samples clustered with isolates 
from India, and the remaining 3 were most closely related 
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to an isolate from Sri Lanka (Figure). Overall, during June, 
dengue NS1 antigen was detected in the serum specimens 
of 194 patients. In 40 other cases, the serum specimens test-
ed positive for dengue IgM by immunochromatography or 
capture ELISA (Panbio, Brisbane, Queensland, Australia) 
but negative for NS1 antigen. All patients were clustered 
in suburbs of Port-Louis or had traveled there. Only 5 and 
3 new cases of dengue were diagnosed in July and August, 
respectively, and no case was reported in September. The 
case-patients ranged in age from1 to 91 years; median age 
was 36 years, and 52.5% were male.
Conclusions
Dengue has reemerged in Mauritius after >30 years, 
but the outbreak was short-lived because of the institu-
tion of control measures and the arrival of cooler and drier 
weather. In the affected areas, monthly mean maximum 
temperature dropped from 28.3°C in June to 26.4°C in 
August, and total monthly rainfall amount fell from 126.4 
mm in May to 44.8 mm in August. The outbreak was also 
restricted to some suburbs of the capital city, possibly be-
cause of of relatively warm temperatures and high popula-
tion density. The reemergence was probably caused by in-
troduction of DENV-2 by unrecognized infective travelers. 
The high bootstrap value of 94% in the phylogenetic analy-
sis suggests at least 2 separate importations of DENV-2 oc-
curred. In 2008, an imported case of dengue was diagnosed 
in a child returning from India, but control measures were 
rapidly instituted and no local transmission occurred. 
No case of dengue hemorrhagic fever was recorded in 
this outbreak, probably because the population has not been 
exposed previously to another serotype. The vector of the 
outbreak was likely to have been Ae. albopictus mosqui-
toes, which are widely distributed in Mauritius (Ae. aegypti 
was eradicated from the country in the early 1950s as a 
result of a DDT indoor-spraying campaign in 1949–1951 
to control malaria) (7). However, the rapid increase in the 
number of observed cases in June is more consistent with 
an Ae. aegypti–borne dengue outbreak, and a new compre-
hensive entomologic study is needed  to exclude the pos-
sibility that Ae. aegypti has recently been reintroduced into 
Mauritius.
Whether DENV-2 will persist in Mauritius through-
out the winter and lead to more cases next summer, despite 
maintenance of intensive mosquito control programs, is 
uncertain However, all practical measures must be taken 
to prevent introduction and transmission of another DENV 
serotype in Mauritius to minimize the risk for dengue hem-
orrhagic fever. In particular, surveillance of travelers from 
dengue-endemic regions should be instituted. The thermal 
scanner, recently installed at Mauritius’ only airport, could 
be used to screen passengers for dengue fever because a 
study from Taiwan suggested that fever screening at air-
ports was a cost-effective means of identifying many im-
ported dengue cases (8). Moreover, the present policy of 
monitoring all persons arriving from malaria-endemic ar-
eas for fever and parasitemia could be extended to include 
testing for dengue in febrile travelers arriving from dengue-
endemic areas. The recently opened CHL molecular biol-
ogy unit needs to be ready by next summer to detect and 
serotype dengue viruses to enable prompt diagnosis and 
epidemiologic evaluation of any new case.
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Figure. Phylogenetic relationships of dengue virus isolates from 
Mauritius inferred by envelope (E) gene sequence by using the 
maximum-likelihood method as implemented in PAUP* version
4.0b10 (http://paup.csit.fsu.edu/about.html). Primers used for 
ampliﬁ   cation of product for sequencing were 5′-AATCCAGATG
TCATCAGGAAAC-3′ and 5′-CCTATAGATGTGAACACTCCTCC-3′. 
The E gene sequences were consolidated from overlapping, 
bidirectional sequences. Scale bar indicates nucleotide substitutions 
per site.Health in Mauritius. His main research interests include the epide-
miology of infectious diseases and antimicrobial drug resistance.
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